Reference Intervals for Platelet Counts in the Elderly: Results from the Prospective SENIORLAB Study

Abstract

Currently, age- and sex-independent reference limits (RLs) are frequently used to interpret platelet counts in seniors. We aimed to define and validate reference intervals (RIs) for platelet counts within the framework of the prospective SENIORLAB study. Subjectively healthy Swiss individuals aged 60 years and older were prospectively included and followed for morbidity and mortality. Participants who had circumstances known to affect platelet counts were excluded. The obtained RIs were validated with indirect statistical methods. Frequencies of abnormal platelet counts in a population-based setting, including 41.5% of the entire age-specific population of the Principality of Liechtenstein, were compared by using age- and sex-independent RIs and the RLs obtained in the present study. For males (n = 542), 95% RIs for platelet counts were defined as follows: 150–300 × 109/L (60–69 years); 130–300 × 109/L (70–79 years); and 120–300 × 109/L (80 years and above). For females (n = 661), the consolidated age-independent 95% RI was 165–355 × 109/L. These RI values were validated by indirect RI determination of 51,687 (30,392 female/21,295 male) patients of the same age. Age- and sex-independent RIs exhibited imbalanced frequencies of abnormal platelet counts between the two sexes, which were corrected by introducing age- and sex-specific RLs. In conclusion, females have higher platelet counts than males. Whereas the upper RL for males remains constant, the lower RL decreases with age. We propose to abandon the practice of employing sex- and age-independent RL for platelet counts in the elderly.

Age-associated modifications in blood counts. The findings from an outpatient population of northern Italy

“…The absence of corresponding changes in white blood cells and in platelet count seem to address towards a rather selective de cit in the bone marrow. This nding, too, is in agreement with the data in the literature [24]. Mean corpuscular values also tended to remain within the normal limits over all age quartiles.…”

Morbidity and Mortality Markers in Elderly Patients with Cardiovascular Surgery

“…Elderly patients who will undergo cardiovascular surgery are at a high risk of coagulopathy and bleeding because of provoking factors as suppressed hematopoietic system, general anesthesia, medications used, prolonged CPB , and hypothermia. In addition, iron deficiency anemia, infections, mechanical heart valves, and disorders triggered by surgical trauma can lead to thrombocytosis/ thrombocytopenia [33] . To have a more accurate postoperative prognosis, evaluating the number of platelets may offer significant data.…”

Supportive Care in Older Lymphoma Patients to Reduce Toxicity and Preserve Quality of Life

“…Thrombocytopenia is frequently observed during chemotherapy for hematological malignancies, ranging from 40% to 68%, and is often associated with anemia [51,69]. It has been widely described that platelet count decreases with age, with a more significant reduction observed in male patients [70,71]. Currently, there is no preventive treatment for thrombocytopenia, which is a frequent cause of loss of dose intensity.…”

“…The incidence and the severity of anemia increases after each additional cycle of antineoplastic treatment [78]. Cancer-associated anemia can be treated with erythropoiesisstimulating agents (ESA), such as epoetin and darbepoetin alfa, to reduce the burden of anemia-related symptoms and the need for a transfusion [70]. The efficacy of these agents is not immediate, but takes 7-14 days to occur.…”